Form 4 for NEO NEOGENOMICS INC
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001077183-22-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-02 | NEO | Brown Douglas Matthew | Chief Strategy Off | F - Tax | $0.00 | -867 | 76.4K | -1% | $0 |
| D | 2022-03-03 | 2022-03-01 | NEO | Brown Douglas Matthew | Chief Strategy Off | A - Grant | $0.00 | +35.0K | 77.2K | +83% | $0 |
| D | 2022-03-03 | 2022-03-01 | NEO | Brown Douglas Matthew | Chief Strategy Off | A - Grant | $0.00 | +85.5K | 85.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-02 | F | D | 867 | $0.00 | 76,379 | D | — | — | (F2) Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2022 vesting of restricted stock. |
| 2 | Common | Common Stock | 2022-03-01 | A | A | 35,030 | $0.00 | 77,246 | D | — | — | (F1) On March 1, 2022, Mr. Brown was granted 35,030 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-03-01 | A | A | 85,519 | $0.00 | 85,519 | D | $21.41 · — to 2029-03-01 | 85,519 Common Stock | (F5) On March 1, 2022, Mr. Brown was granted 85,519 stock options. These options vest ratably over the first four anniversary dates of the grant date. |